Discussion on Body Resistance-Strengthening,Toxin-Resolving and Stasis-Dispelling Therapy for Chemotherapy-Induced Myelosuppression

JIA Yingjie; YU Jianchun; YANG Peiying; WANG Xiaoqun; ZHAO Linlin

doi:10.13288/j.11-2166/r.2014.03.006

您当前的位置：

首页 >

文章列表页 >

Discussion on Body Resistance-Strengthening,Toxin-Resolving and Stasis-Dispelling Therapy for Chemotherapy-Induced Myelosuppression

更新时间：2021-11-17

- Discussion on Body Resistance-Strengthening,Toxin-Resolving and Stasis-Dispelling Therapy for Chemotherapy-Induced Myelosuppression
- Journal of Traditional Chinese Medicine Vol. 55, Issue 3, Pages: 198-201(2014)
- 作者机构：
  
  1. 天津中医药大学第一附属医院
  2. 天津中医药大学研究生院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2014.03.006
  CLC： R273
- Published：2014
- 稿件说明：
移动端阅览
[1]贾英杰,于建春,杨佩颖,王晓群,赵林林.扶正解毒祛瘀法防治化疗后骨髓抑制的探讨[J].中医杂志,2014,55(03):198-201.

JIA Yingjie, YU Jianchun, YANG Peiying, et al. Discussion on Body Resistance-Strengthening,Toxin-Resolving and Stasis-Dispelling Therapy for Chemotherapy-Induced Myelosuppression[J]. Journal of Traditional Chinese Medicine2014, 55(3): 198-201.
[1]贾英杰,于建春,杨佩颖,王晓群,赵林林.扶正解毒祛瘀法防治化疗后骨髓抑制的探讨[J].中医杂志,2014,55(03):198-201. DOI： 10.13288/j.11-2166/r.2014.03.006.

JIA Yingjie, YU Jianchun, YANG Peiying, et al. Discussion on Body Resistance-Strengthening,Toxin-Resolving and Stasis-Dispelling Therapy for Chemotherapy-Induced Myelosuppression[J]. Journal of Traditional Chinese Medicine2014, 55(3): 198-201. DOI： 10.13288/j.11-2166/r.2014.03.006.

摘要

骨髓抑制是恶性肿瘤化疗的最大毒副反应之一

是化疗不能按时足量完成的主要原因。近年来中医药在防治化疗后骨髓抑制方面取得了显著成效

从理论基础、研究概况、用药规律等方面系统阐述扶正解毒祛瘀法防治化疗后骨髓抑制的合理性及可行性。

Abstract

Myelosuppression is one of severe side effects of chemotherapy for cancer and the main reason why chemotherapy cannot be completed.In recent years

traditional Chinese medicine has made remarkable achievements in the prevention and treatment of chemotherapy-induced myelosuppression.The rationality and feasibility of body resistance-strengthening

toxin-resolving and stasis-dispelling therapy for chemotherapy-induced myelosuppression was explained in this article from theoretical foundation

research overview and prescription rules.

关键词

Keywords

references

查看原文

Views

758

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Observation on Shengxue Pills（生血丸） in Preventing and Treating 32 Cases of Chemotherapy-Induced Myelosuppression

Pathophysiological Evolution and Syndrome-Based Stratified Treatment of Qi Deficiency with Stagnation in Chemotherapy-Induced Myelosuppression

Yisui Shengxue Pills （益髓生血丸） as Adjuvant Treatment for Myelosuppression after Chemotherapy for 40 Patients of Malignant Tumours with Qi and Yin Deficiency Syndrome：A Randomised Controlled Trial

Whole Course Management and Therapeutic Strategy of Traditional Chinese Medicine for Thrombocytopenia Induced by Tumor Treatment

Clinical Observation on Yixuesheng Capsule（益血生胶囊） Combined with Western Medicine Treating 40 Cases of Chronic Viral Hepatitis C

Related Author

YU Jianchun

CHEN Liang

YANG Peiying

LI Xiaojiang

ZHAO Linlin

ZHANG Lili

YOU Fengming

LONG Jing

Related Institution

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Chongqing Traditional Chinese Medicine Hospital

Teaching and Research Unit of Oncology，Chengdu University of Traditional Chinese Medicine

Hospital of Traditional Chinese Medicine of Zibo City

Affiliated Cancer Hospital and Institute of Guangzhou Medical University

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰